Skip to content

NC SPRINTER® NCSP37515XRecalls & reported problems

Medtronic, Inc. · BALLOON NCSP37515X NCSPRINTER RX M US · Class 2

All models of NC SPRINTER (13)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169282070), received between Feb 23, 2026 and Feb 23, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel1
  • Detachment of Device or Device Component1
  • Improper or Incorrect Procedure or Method1
  • Material Deformation1

Patient problems

  • Device Embedded In Tissue or Plaque1
  • Insufficient Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 23, 2026Burst Container or Vessel; Improper or Incorrect Procedure or Method; Detachment of Device or Device Component; Material Deformation

    IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING ONE NC SPRINTER RX BALLOON CATHETER, THE BALLOON BURST DURING BALLOON INFLATION AT 20ATM, EXCEEDING THE RATED BURST PRESSURE (RBP) OF 18 ATM. THE TARGET LESION WAS LOCATED IN THE PROXIMAL CIRCUMFLEX (CX) ARTERY WHICH EXHIBITED NO TORTUOSITY AND MODERATE CALCIFICATION. THE DEVICE WAS NOT INSPECTED PRIOR TO USE AND NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED. THE DEVICE WAS NOT KINKED AND RESTRAIGHTENED DURING USE. THE DEVICE DID PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. THE PROXIMAL CIRCUMFLEX LESION WAS PRE-DILATED WITH A 2.5MM NON-COMPLIANT (NC) BALLOON, FOLLOWED BY A 3.0MM NC BALLOON, FOLLOWED BY A 3.5 MM SHOCKWAVE BALLOON. A GUIDELINER WAS THEN USED TO DELIVER A 3.5 X 26 RESOLUTE INTEGRITY STENT. POST-IMPLANT OF THE STENT, A 4.5 MM NC BALLOON WAS USED TO DILATE THE DISTAL AND MID SECTION OF THE STENT. THE 3.75 X 15 NC SPRINTER BALLOON WAS SMOOTHLY DELIVERED TO THE PROXIMAL END OF THE STENT THROUGH THE GUIDELINER AND INFLATED TO 20 ATM. THE BALLOON RUPTURED. THE BALLOON CATHETER WAS WITHDRAWN FRO

    Patient problems: Device Embedded In Tissue or Plaque; Insufficient Information

    MAUDE report 24412986 ↗

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page